Radiopharmaceutical Encapsulated Liposomes as a Novel Radiotracer Im - aging and Drug Delivery Protocol.

IF 1.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Anfal M Alkandari, Yasser M Alsayed, Atallah M El-Hanbaly
{"title":"Radiopharmaceutical Encapsulated Liposomes as a Novel Radiotracer Im - aging and Drug Delivery Protocol.","authors":"Anfal M Alkandari,&nbsp;Yasser M Alsayed,&nbsp;Atallah M El-Hanbaly","doi":"10.2174/1874471016666221202094628","DOIUrl":null,"url":null,"abstract":"<p><p>Nuclear medicine specialty involves the administration of unsealed radioactive substances to patients to allow specific diagnostics and treatments using radiopharmaceuticals, radiotracers, and materials. Developing a radiopharmaceutical must involve considering and addressing some limitations such as its retention by unintended organs, which can influence patient and worker safety, imaging findings, and diagnostic and therapeutic accuracy. This paper presents data on the changing biodistribution, localization, stability, and accuracy patterns of radiopharmaceuticals by liposome encapsulation.</p><p><strong>Methods: </strong>Data are presented for 5 male New Zealand white rabbits. They were injected intravenously with the <sup>99m</sup>Tc-liposomes encapsulated MIBI through a marginal ear vein, and whole-body images were acquired using a dual-head gamma camera. Cationic PEGylated liposomes were prepared using the conventional thin-film-hydration method. The liposomes were tested for particle size, zeta potential, high-performance-liquid-chromatography (HPLC), and toxicity.</p><p><strong>Results: </strong>The liver activity was slightly greater than or equivalent to heart uptake, using <sup>99m</sup>Tcsestamibi, MIBI, without liposome as a reference. The absorbed doses in myocardium cells after injecting rabbits with <sup>99m</sup>Tc-MIBI labeled with free positive lower pH liposomes was greater than in the liver, whereas <sup>99m</sup>Tc labeled with encapsulated MIBI within positive liposomes showed a significantly higher heart-to-liver ratio. The heart-to-spleen activity uptake ratio in <sup>99m</sup>Tc-MIBI was higher than or equal to one but increased in <sup>99m</sup>Tc labeled with MIBI and free positive liposomes. Injecting rabbits with <sup>99m</sup>Tc labeled with encapsulated MIBI raised myocardium uptake to 2-4 times more than the spleen. Heart-to-bowel activity began to rise with 99m Tc-labeld-MIBI and liposomes.</p><p><strong>Conclusion: </strong>This study provides findings in radiopharmaceutical biodistribution using liposomal agents. Adding free liposomes using a pH gradient technique enhanced the uptake and localization of the radiotracer. However, tracer encapsulation during the formation of the liposomes showed even better specificity.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":"16 2","pages":"133-139"},"PeriodicalIF":1.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current radiopharmaceuticals","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1874471016666221202094628","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

Abstract

Nuclear medicine specialty involves the administration of unsealed radioactive substances to patients to allow specific diagnostics and treatments using radiopharmaceuticals, radiotracers, and materials. Developing a radiopharmaceutical must involve considering and addressing some limitations such as its retention by unintended organs, which can influence patient and worker safety, imaging findings, and diagnostic and therapeutic accuracy. This paper presents data on the changing biodistribution, localization, stability, and accuracy patterns of radiopharmaceuticals by liposome encapsulation.

Methods: Data are presented for 5 male New Zealand white rabbits. They were injected intravenously with the 99mTc-liposomes encapsulated MIBI through a marginal ear vein, and whole-body images were acquired using a dual-head gamma camera. Cationic PEGylated liposomes were prepared using the conventional thin-film-hydration method. The liposomes were tested for particle size, zeta potential, high-performance-liquid-chromatography (HPLC), and toxicity.

Results: The liver activity was slightly greater than or equivalent to heart uptake, using 99mTcsestamibi, MIBI, without liposome as a reference. The absorbed doses in myocardium cells after injecting rabbits with 99mTc-MIBI labeled with free positive lower pH liposomes was greater than in the liver, whereas 99mTc labeled with encapsulated MIBI within positive liposomes showed a significantly higher heart-to-liver ratio. The heart-to-spleen activity uptake ratio in 99mTc-MIBI was higher than or equal to one but increased in 99mTc labeled with MIBI and free positive liposomes. Injecting rabbits with 99mTc labeled with encapsulated MIBI raised myocardium uptake to 2-4 times more than the spleen. Heart-to-bowel activity began to rise with 99m Tc-labeld-MIBI and liposomes.

Conclusion: This study provides findings in radiopharmaceutical biodistribution using liposomal agents. Adding free liposomes using a pH gradient technique enhanced the uptake and localization of the radiotracer. However, tracer encapsulation during the formation of the liposomes showed even better specificity.

放射性药物包封脂质体作为一种新型放射性示踪剂——老化与给药方案。
核医学专业涉及给病人使用未密封的放射性物质,以便使用放射性药物、放射性示踪剂和材料进行特定的诊断和治疗。开发一种放射性药物必须考虑和解决一些限制,例如被意外器官滞留,这可能影响患者和工作人员的安全、成像结果以及诊断和治疗的准确性。本文介绍了通过脂质体封装改变放射性药物的生物分布、定位、稳定性和准确性模式的数据。方法:对5只雄性新西兰大白兔进行资料分析。他们通过耳缘静脉静脉注射99mtc脂质体包裹的MIBI,并使用双头伽马相机获得全身图像。采用常规薄膜水合法制备了阳离子聚乙二醇脂质体。对脂质体进行了粒径、zeta电位、高效液相色谱(HPLC)和毒性测试。结果:以99mTcsestamibi, MIBI,不含脂质体为对照,肝脏活性略大于或等于心脏摄取。经游离低pH阳性脂质体标记的99mTc-MIBI在兔心肌细胞内的吸收剂量大于肝脏,而在阳性脂质体内包封MIBI标记的99mTc心肝比明显升高。99mTc-MIBI组心脏-脾脏活动摄取比大于或等于1,而MIBI和游离阳性脂质体标记的99mTc组心脏-脾脏活动摄取比增加。给家兔注射包封MIBI标记的99mTc,心肌摄取比脾脏高2-4倍。99m tc标记的mibi和脂质体开始增加心肠活动。结论:本研究提供了利用脂质体进行放射性药物生物分布的研究结果。使用pH梯度技术添加游离脂质体增强了放射性示踪剂的吸收和定位。然而,在脂质体形成过程中,示踪剂包封表现出更好的特异性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current radiopharmaceuticals
Current radiopharmaceuticals PHARMACOLOGY & PHARMACY-
CiteScore
3.20
自引率
4.30%
发文量
43
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信